ロード中...
Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
Cyclooxygenase-2 (COX-2) is reported to be activated during the course of amyotrophic lateral sclerosis (ALS) development and progression. However, the roles of COX-2 in aggravating ALS and the underlying mechanism have been largely overlooked. To reveal the mechanisms, the canonical SOD1G93A mouse...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020-08-01
|
| シリーズ: | Frontiers in Neuroscience |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/article/10.3389/fnins.2020.00817/full |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|